- Virus-blocking portfolio: selected products / countries available
- Anti-allergy nasal spray: Global or territorial license available
- Ophthalmic application: Global or territorial license available
- Private label possible
- Long term partnership requested
Marinomed is further in contact with companies, which are interested in developing new products based on the Carragelose® platform. Carragelose® can be used to extend or enhance existing therapies through its virus-blocking, allergen-blocking and moistuirizing effectiveness. One of our examples is the decongestant combination, which received EU-wide certification in July 2018.